AEON Biopharma, Inc.·4

Sep 4, 9:49 PM ET

PALMISANO ROBERT J 4

4 · AEON Biopharma, Inc. · Filed Sep 4, 2024

Insider Transaction Report

Form 4
Period: 2024-08-31
Transactions
  • Award

    Class A Common Stock

    2024-08-31+36,02136,021 total
  • Award

    Stock Option

    2024-08-31+96,21096,210 total
    Exercise: $0.83Exp: 2034-08-30Class A Common Stock (96,210 underlying)
Footnotes (2)
  • [F1]Represents an award of restricted stock units granted on August 31, 2024 (the "Grant Date"), which vests in full on the second anniversary of the Grant Date, subject to the reporting person's continued service through the applicable vesting date.
  • [F2]Represents an award of stock options granted on August 31, 2024 (the "Grant Date"), which vest and become exercisable in substantially equal monthly installments over the eighteen months following the Grant Date, subject to the reporting person's continued service through the applicable vesting date.

Documents

1 file
  • 4
    tm2423415-6_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT